CD274 and neoplasm: Moreover, Chang et al. showed that PD-L1 expression of treated BCCs (treatment with HHI, platinum chemotherapy, gefitinib, topycal chemotherapy, surgery, and radiotherapy) was significantly increased in tumor cells and tumor-infiltrating lymphocytes compared with treatment-naïve BCCs (32% vs. 7%, respectively) [34].